Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. [electronic resource]
Producer: 20011101Description: 2328-32 p. digitalISSN:- 1524-4628
- Abciximab
- Adjuvants, Pharmaceutic -- therapeutic use
- Aged
- Antibodies, Monoclonal -- adverse effects
- Blood Vessel Prosthesis Implantation -- adverse effects
- Carotid Artery Diseases -- surgery
- Female
- Graft Occlusion, Vascular -- etiology
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Intracranial Hemorrhages -- etiology
- Male
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Risk Assessment
- Risk Factors
- Stents -- adverse effects
- Thromboembolism -- etiology
- Treatment Outcome
- Urokinase-Type Plasminogen Activator -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.